Fundraising Fox

SeLux Diagnostics, Inc.

Charlestown, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

ES
Eric SternExecutive Officer, Director, Promoter
JP
James Parker CassidyDirector
SY
Scott YapheDirector
SE
Steven E. LufkinExecutive Officer, Director
AV
Aleksandar VacicExecutive Officer, Promoter
MR
Michael RubinDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$40MraisedFeb 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michele HealyExecutive Officer
  • Jamie CondieDirector
  • Orhan GazelleDirector
  • John WilsonExecutive Officer
  • Eric SternExecutive Officer, Director
  • Ingo ChakravartyDirector
  • Steven E. LufkinExecutive Officer, Director
  • James Parker CassidyDirector
  • Erich SchellerDirector
  • Adam SteelExecutive Officer
  • Aleksandar VacicExecutive Officer
Offering amount
$45M
Amount sold
$40M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$48.2MraisedFeb 2022 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott YapheDirector
  • Aleksandar VacicExecutive Officer
  • James Parker CassidyDirector
  • Eric SternExecutive Officer, Director
  • Erich SchellerDirector
  • Jack PercoskieExecutive Officer
  • Steven E. LufkinExecutive Officer, Director
Offering amount
$57.6M
Amount sold
$48.2M
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.5MraisedJun 2021 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven E. LufkinExecutive Officer, Director
  • Parker CassidyDirector
  • Vacic AlexanderExecutive Officer
  • Stephen ZacharyDirector
  • Eric SternExecutive Officer, Director
  • Jack PercoskieExecutive Officer
  • Scott YapheDirector
Offering amount
$7.5M
Amount sold
$2.5M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$813.9KraisedOct 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven E. LufkinExecutive Officer, Director
  • Aleksandar VacicExecutive Officer, Promoter
  • Eric SternExecutive Officer, Director, Promoter
  • James Parker CassidyDirector
  • Stephen ZacharyDirector
  • Jack PercoskieExecutive Officer
  • Scott YapheDirector
Offering amount
$1.7M
Amount sold
$813.9K
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$9MraisedSep 2019 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven E. LufkinExecutive Officer, Director
  • Aleksandar VacicExecutive Officer, Promoter
  • Eric SternExecutive Officer, Director, Promoter
  • James Parker CassidyDirector
  • Scott YapheDirector
  • Stephen ZacharyDirector
Offering amount
$9M
Amount sold
$9M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$23.5MraisedApr 2018 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric SternExecutive Officer, Director, Promoter
  • James Parker CassidyDirector
  • Scott YapheDirector
  • Steven E. LufkinExecutive Officer, Director
  • Aleksandar VacicExecutive Officer, Promoter
  • Michael RubinDirector
Offering amount
$25M
Amount sold
$23.5M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.